Kestra Advisory Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Kestra Advisory Services's DGX Position: Q2 2026 in Review
Kestra Advisory Services increased its Quest Diagnostics (DGX) stake by 0.79% in Q2 2026, buying an estimated $27.7K and bringing the position to 18,027 shares worth $3.82M. The position accounts for 0.01% of the portfolio, ranked #990.
Kestra Advisory Services first reported a position in DGX in Q3 2020 and has held it in 24 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Kestra Advisory Services held 18,027 shares of Quest Diagnostics worth $3.82M as of Q2 2026.
- Kestra Advisory Services bought 141 Quest Diagnostics shares in Q2 2026, an estimated $27.7K.
- Quest Diagnostics made up 0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #990 holding.
- Kestra Advisory Services first reported a position in Quest Diagnostics in Q3 2020 and has held it in 24 quarters since.
- 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.